Pendopharm is focused on in-licensing innovative products for the Canadian market.

At Pendopharm, our mission to bring innovative products to Canadian patients is the driving force behind our partnering strategy. We offer the flexibility and timely decision-making of a smaller company, while providing the infrastructure and resources of a large pharmaceutical corporation.

Our seasoned commercial, medical and market access professionals have extensive experience in the commercialization of branded specialty pharmaceuticals and have a proven track record in successfully bringing products to the Canadian market.

The agility of a small organization, the resources of a large pharmaceutical corporation.

Why Partner with Us?

  • Fast decision-making
  • Collaborative and flexible partnership structures
  • Strong alliance management
  • In-house expertise across all functional areas, including sales & marketing, market access and medical & regulatory affairs
  • Commitment to commercial success of products

Our Areas of Focus

Pendopharm’s strategy is to leverage its existing commercial structure with the licensing or acquisition of late-stage or commercial assets in gastroenterology, sports medicine & orthopedics, neurology and cardiology. We are also open to exploring partnerships in other therapeutic areas, provided the assets are differentiated and address unmet medical needs.

Collaboration and partnership drive our success – we rely on our suppliers, development partners, licensors, and customers to bring innovative and differentiated products to patients. We are open to ideas and opportunities from those that share our values and vision, and we look forward to helping patients together with you.  

Paul Evans
Vice President, Global Business Development